智通财经APP获悉，周三，吉利德科学(GILD.US)涨逾5%，报155.54美元，股价再创历史新高。吉利德科学最新公布的财报显示，2025年全年公司营业收入达294.43亿美元，同比增长2.4%；归属上市公司净利润85.1亿美元，同比大幅增长约16.73倍，非公认会计原则(Non-GAAP)稀释后每股收益8.15美元，同比大幅增长77%。
吉利德董事长兼首席执行官丹尼尔奥戴介绍，去年是公司成果丰硕的一年，全球首款半年一次HIV预防疗法Yeztugo成功上市，必妥维(Biktarvy)与Descovy持续增长，为公司奠定了坚实的增长基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.